Publications by authors named "Amy Barone"

Claim this Profile
F
FDA Approval Summary: Vorasidenib for IDH-Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery.
Michael I Barbato, Amy K Barone, Stephanie L Aungst, Claudia P Miller, Suryatheja Ananthula

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of External Control Cohorts in Pediatric Brain Tumor Clinical Trials.
Ashley S Margol, Annette M Molinaro, Arzu Onar-Thomas, Adam Resnick, Derek Hanson, Amy Barone

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Andrew Dj Pearson, Carl Allen, Jason Fangusaro, Caroline Hutter, Olaf Witt, Amy Barone

Eur J Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Cabozantinib for Differentiated Thyroid Cancer.
Elizabeth S Duke, Amy K Barone, Somak Chatterjee, Pallavi S Mishra-Kalyani, Yuan-Li Shen

Clin Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.
Andrew D J Pearson, Elly Barry, Yael P Mossé, Franca Ligas, Nick Bird, Amy Barone

Eur J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience.
Eudocia Q Lee, Wendy Selig, Clair Meehan, Jeffrey Bacha, Amy Barone

Neuro Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US Food and Drug Administration regulatory updates in neuro-oncology.
Gautam U Mehta, Amy K Barone, Diana Bradford, Erin Larkins, Janice Kim

J Neurooncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trials.
Benjamin M Ellingson, Matthew S Brown, Jerrold L Boxerman, Elizabeth R Gerstner, Timothy J Kaufmann, Amy Barone

Neuro Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Andrew Dj Pearson, Kimberly Stegmaier, Franck Bourdeaut, Gregory Reaman, Delphine Heenen, Amy Barone

Eur J Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer drugs approved for use in children: Impact of legislative initiatives and future opportunities.
Amy Barone, Denise Casey, Amy E McKee, Gregory Reaman

Pediatr Blood Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric Development of Molecularly Targeted Oncology Drugs.
Shivam Kamlesh Patel, Ruby Leong, Hong Zhao, Amy Barone, Denise Casey

Clin Pharmacol Ther· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-FDOPA PET/MRI for monitoring early response to bevacizumab in children with recurrent brain tumors.
Karen Gauvain, Maria Rosana Ponisio, Amy Barone, Michael Grimaldi, Ephraim Parent

Neurooncol Pract· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis.
Julia A Beaver, Maitreyee Hazarika, Flora Mulkey, Sirisha Mushti, Huanyu Chen, Amy Barone

Lancet Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Trabectedin for Unresectable or Metastatic Liposarcoma or Leiomyosarcoma Following an Anthracycline-Containing Regimen.
Amy Barone, Dow-Chung Chi, Marc R Theoret, Huanyu Chen, Kun He

Clin Cancer Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma.
Amy Barone, Maitreyee Hazarika, Marc R Theoret, Pallavi Mishra-Kalyani, Huanyu Chen

Clin Cancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactions.
Rajarshi Sengupta, Amy Barone, Jayne Marasa, Sara Taylor, Erin Jackson

Oncotarget· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma.
Amy Barone, Rajarshi Sengupta, Nicole M Warrington, Erin Smith, Patrick Y Wen

Oncotarget· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities and challenges for successful use of bevacizumab in pediatrics.
Amy Barone, Joshua B Rubin

Front Oncol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factor X Umuahia: a severe bleeding diathesis associated with a novel mutation.
Amy Barone, Jeffrey Campbell, Gregory Griffin, Marium Hill

Pediatr Blood Cancer· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis